{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:17:31Z","timestamp":1790630251170,"version":"4.1.0"},"reference-count":155,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,4]],"date-time":"2026-12-04T00:00:00Z","timestamp":1796342400000},"content-version":"am","delay-in-days":306,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203609"],"award-info":[{"award-number":["82203609"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008866","name":"Changhai Hospital of Shanghai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008866","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.cytogfr.2025.12.001","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:26:19Z","timestamp":1764721579000},"page":"19-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The IL-17 axis in gastric carcinogenesis: From inflammation to oncogenic transformation"],"prefix":"10.1016","volume":"87","author":[{"given":"Zhaojie","family":"Lyu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mancang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengmao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peixin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoshen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4225-9200","authenticated-orcid":false,"given":"Lei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cytogfr.2025.12.001_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clini."},{"issue":"7","key":"10.1016\/j.cytogfr.2025.12.001_bib2","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/cac2.12318","article-title":"Survival trends of patients with non-metastatic gastric adenocarcinoma in the US and European countries: the impact of decreasing resection rates","volume":"42","author":"Huang","year":"2022","journal-title":"Cancer commun."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.001_bib3","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"12","key":"10.1016\/j.cytogfr.2025.12.001_bib4","doi-asserted-by":"crossref","first-page":"e943","DOI":"10.1016\/S2468-2667(23)00211-6","article-title":"National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data","volume":"8","author":"Qi","year":"2023","journal-title":"Lancet Public Health"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.001_bib5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s10020-025-01075-y","article-title":"Targeted therapy and immunotherapy for gastric cancer: rational strategies, novel advancements, challenges, and future perspectives","volume":"31","author":"Luo","year":"2025","journal-title":"Mol. Med."},{"issue":"12","key":"10.1016\/j.cytogfr.2025.12.001_bib6","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1136\/gutjnl-2020-322368","article-title":"Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus","volume":"69","author":"Liou","year":"2020","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.cytogfr.2025.12.001_bib7","doi-asserted-by":"crossref","first-page":"e888","DOI":"10.1016\/S2468-2667(21)00164-X","article-title":"The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China: a case-cohort study","volume":"6","author":"Yang","year":"2021","journal-title":"Lancet Public Health"},{"issue":"8336","key":"10.1016\/j.cytogfr.2025.12.001_bib8","first-page":"1273","article-title":"Unidentified curved bacilli on gastric epithelium in active chronic gastritis","volume":"1","author":"Warren","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2025.12.001_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.557638","article-title":"Tumor-infiltrating immune cell signature predicts the prognosis and chemosensitivity of patients with pancreatic ductal adenocarcinoma","volume":"10","author":"Gao","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.001_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","article-title":"Helicobacter pylori infection","volume":"9","author":"Malfertheiner","year":"2023","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.12.001_bib11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s12029-014-9583-1","article-title":"H. pylori Infection, inflammation and gastric cancer","volume":"45","author":"Qadri","year":"2014","journal-title":"J. Gastrointest. Cancer"},{"issue":"6","key":"10.1016\/j.cytogfr.2025.12.001_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.203","article-title":"Decreasing resection rates for nonmetastatic gastric cancer in Europe and the United States","volume":"10","author":"Huang","year":"2020","journal-title":"Clin. Transl. Med."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.12.001_bib13","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1158\/1078-0432.CCR-16-0617","article-title":"Interleukin-17-Producing Neutrophils Link Inflammatory Stimuli to Disease Progression by Promoting Angiogenesis in Gastric Cancer, Clinical cancer research","volume":"23","author":"Li","year":"2017","journal-title":"Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.cytogfr.2025.12.001_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2025.107741","article-title":"Exploring IL-17 and IL-23 as biomarkers in H. pylori-linked gastric diseases: A cross-sectional study","volume":"206","author":"Al-Shawk","year":"2025","journal-title":"Microb. Pathog."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.001_bib15","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2430421","article-title":"IL-17 signaling protects against Helicobacter pylori-induced gastric cancer","volume":"16","author":"Brackman","year":"2024","journal-title":"Gut Microbes"},{"issue":"10","key":"10.1016\/j.cytogfr.2025.12.001_bib16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrd3794","article-title":"Targeting IL-17 and TH17 cells in chronic inflammation","volume":"11","author":"Miossec","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.cytogfr.2025.12.001_bib17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nri2800","article-title":"Innate IL-17-producing cells: the sentinels of the immune system","volume":"10","author":"Cua","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.12.001_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13050315","article-title":"The Roles of IL-17, IL-21, and IL-23 in the Helicobacter pylori Infection and Gastrointestinal Inflammation: A Review","volume":"13","author":"Dewayani","year":"2021","journal-title":"Toxins (Basel)"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.001_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.7150\/ijbs.7.53","article-title":"Intratumoral expression of IL-17 and its prognostic role in gastric adenocarcinoma patients","volume":"7","author":"Chen","year":"2011","journal-title":"Int J. Biol. Sci."},{"issue":"18","key":"10.1016\/j.cytogfr.2025.12.001_bib20","doi-asserted-by":"crossref","first-page":"13447","DOI":"10.1074\/jbc.M700499200","article-title":"Identification of an interleukin 17F\/17A heterodimer in activated human CD4+ T cells","volume":"282","author":"Wright","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.12.001_bib21","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.cytogfr.2025.12.001_bib22","first-page":"1271","article-title":"Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer","volume":"25","author":"Iida","year":"2011","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.12.001_bib23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2567.2009.03240.x","article-title":"Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease","volume":"129","author":"Onishi","year":"2010","journal-title":"Immunology"},{"issue":"9","key":"10.1016\/j.cytogfr.2025.12.001_bib24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri3707","article-title":"The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.001_bib25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaci.2020.12.628","article-title":"IL-25 (IL-17E) in epithelial immunology and pathophysiology","volume":"148","author":"Borowczyk","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.001_bib26","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4049\/jimmunol.169.1.443","article-title":"New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25","volume":"169","author":"Hurst","year":"2002","journal-title":"Journal immunology (Baltimore Md. 1950)"},{"issue":"3","key":"10.1016\/j.cytogfr.2025.12.001_bib27","article-title":"Dynamic changes of the immune microenvironment in the development of gastric cancer caused by inflammation","volume":"32","author":"Gan","year":"2024","journal-title":"Mol. Ther. Oncol."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.12.001_bib28","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S1074-7613(01)00243-6","article-title":"IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo","volume":"15","author":"Fort","year":"2001","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.cytogfr.2025.12.001_bib29","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4049\/jimmunol.169.2.642","article-title":"Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis","volume":"169","author":"Starnes","year":"2002","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.12.001_bib30","first-page":"7002","article-title":"Increased chemokine receptor IL-17RA expression is associated with poor survival in gastric cancer patients","volume":"8","author":"Jiang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"43","key":"10.1016\/j.cytogfr.2025.12.001_bib31","doi-asserted-by":"crossref","first-page":"32751","DOI":"10.1074\/jbc.M110.121418","article-title":"SEF\/IL-17R (SEFIR) is not enough: an extended SEFIR domain is required for il-17RA-mediated signal transduction","volume":"285","author":"Onishi","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.cytogfr.2025.12.001_bib32","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.001_bib33","article-title":"Helicobacter pylori subdues cytokine signaling to alter mucosal inflammation via hypermethylation of suppressor of cytokine Signaling 1 gene during gastric carcinogenesis","volume":"10","author":"Jan","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cytogfr.2025.12.001_bib34","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3389\/fimmu.2018.01682","article-title":"The IL-17 family of cytokines in psoriasis: IL-17A and beyond","volume":"9","author":"Brembilla","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.001_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-5378.2010.00812.x","article-title":"The role of interleukin-17 in the Helicobacter pylori induced infection and immunity","volume":"16","author":"Kabir","year":"2011","journal-title":"Helicobacter"},{"issue":"6","key":"10.1016\/j.cytogfr.2025.12.001_bib36","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.4251\/wjgo.v16.i6.2555","article-title":"N6-methyladenosine methylation regulates the tumor microenvironment of Epstein-Barr virus-associated gastric cancer","volume":"16","author":"Zhang","year":"2024","journal-title":"World J. Gastrointest. Oncol."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.12.001_bib37","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3892\/mco.2013.134","article-title":"Increased IL-17 production correlates with immunosuppression involving myeloid-derived suppressor cells and nutritional impairment in patients with various gastrointestinal cancers","volume":"1","author":"Yazawa","year":"2013","journal-title":"Mol. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.cytogfr.2025.12.001_bib38","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1128\/IAI.72.9.5019-5026.2004","article-title":"Extracellular signal-regulated protein kinase mediates interleukin 17 (IL-17)-induced IL-8 secretion in Helicobacter pylori-infected human gastric epithelial cells","volume":"72","author":"Sebkova","year":"2004","journal-title":"Infect. Immun."},{"issue":"61","key":"10.1016\/j.cytogfr.2025.12.001_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd1287","article-title":"The m(6)A reader IMP2 directs autoimmune inflammation through an IL-17- and TNF\u03b1-dependent C\/EBP transcription factor axis","volume":"6","author":"Bechara","year":"2021","journal-title":"Sci. Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.12.001_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148514","article-title":"IL-17a and IL-22 Induce Expression of Antimicrobials in Gastrointestinal Epithelial Cells and May Contribute to Epithelial Cell Defense against Helicobacter pylori","volume":"11","author":"Dixon","year":"2016","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.cytogfr.2025.12.001_bib41","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s13277-013-1217-x","article-title":"Analysis of the association of interleukin-17 gene polymorphisms with gastric cancer risk and interaction with Helicobacter pylori infection in a Chinese population","volume":"35","author":"Zhang","year":"2014","journal-title":"Tumour Biol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.001_bib42","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s10120-022-01342-5","article-title":"IL-17A promotes Helicobacter pylori-induced gastric carcinogenesis via interactions with IL-17RC","volume":"26","author":"Kang","year":"2023","journal-title":"Gastric Cancer"},{"issue":"6","key":"10.1016\/j.cytogfr.2025.12.001_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061662","article-title":"Increased IL-17A Serum Levels and Gastric Th17 Cells in Helicobacter pylori-Infected Patients with Gastric Premalignant Lesions","volume":"15","author":"Della Bella","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"20","key":"10.1016\/j.cytogfr.2025.12.001_bib44","doi-asserted-by":"crossref","first-page":"8709","DOI":"10.7314\/APJCP.2014.15.20.8709","article-title":"Meta-analysis of associations between interleukin-17 gene polymorphisms and risk of gastric cancer","volume":"15","author":"Yu","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"10","key":"10.1016\/j.cytogfr.2025.12.001_bib45","first-page":"17623","article-title":"Association of interleukin-17 gene polymorphisms and Helicobacter pylori infection with gastric cancer susceptibility: a cumulative and comprehensive meta-analysis","volume":"8","author":"Li","year":"2015","journal-title":"Int J. Clin. Exp. Med"},{"key":"10.1016\/j.cytogfr.2025.12.001_bib46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2302\/kjm.51.supplement2_63","article-title":"H. pylori infection and the development of gastric cancer","volume":"51","author":"Uemura","year":"2002","journal-title":"Keio J. Med"},{"key":"10.1016\/j.cytogfr.2025.12.001_bib47","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cyto.2017.06.013","article-title":"Gastric expression of IL-17A and IFN\u03b3 in Helicobacter pylori infected individuals is related to symptoms","volume":"99","author":"Adamsson","year":"2017","journal-title":"Cytokine"},{"issue":"7","key":"10.1016\/j.cytogfr.2025.12.001_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131444","article-title":"Defining the Roles of IFN-\u03b3 and IL-17A in Inflammation and Protection against Helicobacter pylori Infection","volume":"10","author":"Sj\u00f6kvist Ottsj\u00f6","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2025.12.001_bib49","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fimmu.2012.00056","article-title":"IL-23 Contributes to control of chronic helicobacter pylori infection and the development of T helper responses in a mouse model","volume":"3","author":"Horvath","year":"2012","journal-title":"Front. Immunol."},{"issue":"40","key":"10.1016\/j.cytogfr.2025.12.001_bib50","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.3748\/wjg.v11.i40.6305","article-title":"Interleukin-17 levels in Helicobacter pylori-infected gastric mucosa and pathologic sequelae of colonization","volume":"11","author":"Mizuno","year":"2005","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.12.001_bib51","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/eji.200737635","article-title":"IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa","volume":"38","author":"Caruso","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.12.001_bib52","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.cell.2022.01.017","article-title":"Mucosal fungi promote gut barrier function and social behavior via Type 17 immunity","volume":"185","author":"Leonardi","year":"2022","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.cytogfr.2025.12.001_bib53","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nri2433","article-title":"Cytokine-mediated regulation of antimicrobial proteins","volume":"8","author":"Kolls","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.001_bib54","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cyto.2010.12.019","article-title":"The CCAAT\/enhancer (C\/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulation","volume":"54","author":"Tsukada","year":"2011","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.cytogfr.2025.12.001_bib55","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.immuni.2011.02.012","article-title":"Functional specialization of interleukin-17 family members","volume":"34","author":"Iwakura","year":"2011","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.001_bib56","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-producing cells in protection versus pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.001_bib57","first-page":"187","article-title":"The Helicobacter pylori Type IV Secretion System Encoded by the cag Pathogenicity Island: Architecture, Function, and Signaling","volume":"413","author":"Backert","year":"2017","journal-title":"Curr. Top. Microbiol Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.001_bib58","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.3389\/fmicb.2020.01592","article-title":"Four Chromosomal Type IV Secretion Systems in Helicobacter pylori: Composition, Structure and Function","volume":"11","author":"Fischer","year":"2020","journal-title":"Front Microbiol"},{"issue":"7","key":"10.1016\/j.cytogfr.2025.12.001_bib59","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/odi.12598","article-title":"IL-17: overview and role in oral immunity and microbiome","volume":"23","author":"Abusleme","year":"2017","journal-title":"Oral. Dis."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.12.001_bib60","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.4049\/jimmunol.181.4.2799","article-title":"The human IL-17F\/IL-17A heterodimeric cytokine signals through the IL-17RA\/IL-17RC receptor complex","volume":"181","author":"Wright","year":"2008","journal-title":"Journal immunology (Baltimore Md. 1950)"},{"key":"10.1016\/j.cytogfr.2025.12.001_bib61","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00389-17","article-title":"Interleukin-17C in Human Helicobacter pylori Gastritis","volume":"85","author":"Tanaka","year":"2017","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cytogfr.2025.12.001_bib62","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-3083.2010.02469.x","article-title":"IL-17A and IL-17F Gene Expression is Strongly Induced in the Mucosa of H. pylori-Infected Subjects From Kenya and Germany","volume":"72","author":"Kimang\u2019a","year":"2010","journal-title":"Scand. J. Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.12.001_bib63","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1128\/IAI.00524-09","article-title":"Helicobacter pylori stimulates dendritic cells to induce interleukin-17 expression from CD4+ T lymphocytes","volume":"78","author":"Khamri","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cytogfr.2025.12.001_bib64","first-page":"1","article-title":"Inflammation, immunity, and vaccine development for the gastric pathogen Helicobacter pylori","volume":"421","author":"Ikuse","year":"2019","journal-title":"Curr. Top. Microbiol Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.001_bib65","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1053\/j.gastro.2008.09.017","article-title":"Vaccination of mice against H pylori induces a strong Th-17 response and immunity that is neutrophil dependent","volume":"136","author":"DeLyria","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cytogfr.2025.12.001_bib66","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.cytogfr.2025.12.001_bib67","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.4049\/jimmunol.161.11.6383","article-title":"IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines","volume":"161","author":"Schwarzenberger","year":"1998","journal-title":"Journal immunology (Baltimore Md. 1950)"},{"issue":"8","key":"10.1016\/j.cytogfr.2025.12.001_bib68","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41584-018-0044-2","article-title":"IL-17 in the immunopathogenesis of spondyloarthritis","volume":"14","author":"Taams","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"issue":"10","key":"10.1016\/j.cytogfr.2025.12.001_bib69","doi-asserted-by":"crossref","first-page":"7128","DOI":"10.4049\/jimmunol.179.10.7128","article-title":"IL-17B and IL-17C are associated with TNF-alpha production and contribute to the exacerbation of inflammatory arthritis","volume":"179","author":"Yamaguchi","year":"2007","journal-title":"Journal immunology (Baltimore Md. 1950)"},{"key":"10.1016\/j.cytogfr.2025.12.001_bib70","first-page":"6265150","article-title":"Proinflammatory cytokine IL-17 shows a significant association with helicobacter pylori infection and disease severity","volume":"2017","author":"Arachchi","year":"2017","journal-title":"Gastroenterol. Res Pr."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.001_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053798","article-title":"Stromal cells induce Th17 during Helicobacter pylori infection and in the gastric tumor microenvironment","volume":"8","author":"Pinchuk","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.cytogfr.2025.12.001_bib72","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/j.1349-7006.2009.01291.x","article-title":"Gastric mucosal interleukin-17 and -18 mRNA expression in Helicobacter pylori-induced Mongolian gerbils","volume":"100","author":"Sugimoto","year":"2009","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.001_bib73","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/iji.12705","article-title":"Replication Study and Meta-Analysis of the Contribution of Seven Genetic Polymorphisms in Immune-Related Genes to the Risk of Gastric and Colorectal Cancers","volume":"52","author":"Zhou","year":"2025","journal-title":"Int J. Immunogenet."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.12.001_bib74","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1523-5378.2008.00629.x","article-title":"IL-17 is involved in Helicobacter pylori-induced gastric inflammatory responses in a mouse model","volume":"13","author":"Shiomi","year":"2008","journal-title":"Helicobacter"},{"issue":"2","key":"10.1016\/j.cytogfr.2025.12.001_bib75","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bbrc.2009.02.107","article-title":"Anti-inflammatory effects of IL-17A on Helicobacter pylori-induced gastritis","volume":"382","author":"Otani","year":"2009","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.cytogfr.2025.12.001_bib76","article-title":"Interleukin 17A Promotes Gastric Cancer Invasiveness via NF-\u03baB Mediated Matrix Metalloproteinases 2 and 9 Expression","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.cytogfr.2025.12.001_bib77","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/ncb2976","article-title":"Oncogenic roles of EMT-inducing transcription factors","volume":"16","author":"Puisieux","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cytogfr.2025.12.001_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155830","article-title":"HuR confers IL-17a-induced migration and invasion of gastric cancer cells via upregulation of Snail translation","volume":"153","author":"Liu","year":"2022","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.cytogfr.2025.12.001_bib79","first-page":"440","article-title":"IL-17 induces EMT via Stat3 in lung adenocarcinoma","volume":"6","author":"Huang","year":"2016","journal-title":"Am. J. Cancer Res."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.12.001_bib80","first-page":"1169","article-title":"Interleukin-17-induced EMT promotes lung cancer cell migration and invasion via NF-\u03baB\/ZEB1 signal pathway","volume":"5","author":"Gu","year":"2015","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.001_bib81","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13046-018-1003-0","article-title":"Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells","volume":"38","author":"Li","year":"2019","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.cytogfr.2025.12.001_bib82","article-title":"Intratumoral Fusobacterium nucleatum Recruits Tumor-Associated Neutrophils to Promote Gastric Cancer Progression and Immune Evasion","author":"Zhang","year":"2025","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2025.12.001_bib83","article-title":"Peripheral blood neutrophils contribute to Claudin18.2-specific CAR-T cell treatment resistance in advanced gastric cancer","author":"Li","year":"2025","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.cytogfr.2025.12.001_bib84","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1182\/blood-2002-05-1461","article-title":"Interleukin-17 promotes angiogenesis and tumor growth","volume":"101","author":"Numasaki","year":"2003","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.12.001_bib85","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1007\/s13277-015-4372-4","article-title":"IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer","volume":"37","author":"Wu","year":"2016","journal-title":"Tumour Biol."},{"issue":"15","key":"10.1016\/j.cytogfr.2025.12.001_bib86","first-page":"3698","article-title":"Interleukin 17, a T-cell-derived Cytokine, Promotes Tumorigenicity of Human Cervical Tumors in Nude Mice1","volume":"59","author":"Tartour","year":"1999","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.cytogfr.2025.12.001_bib87","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1084\/jem.20090207","article-title":"IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway","volume":"206","author":"Wang","year":"2009","journal-title":"J. Exp. Med"},{"issue":"12","key":"10.1016\/j.cytogfr.2025.12.001_bib88","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1038\/s41388-021-01699-4","article-title":"IL-17B\/IL-17RB signaling cascade contributes to self-renewal and tumorigenesis of cancer stem cells by regulating Beclin-1 ubiquitination","volume":"40","author":"Bie","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2025.12.001_bib89","doi-asserted-by":"crossref","first-page":"25447","DOI":"10.1038\/srep25447","article-title":"Non-tumor tissue derived interleukin-17B activates IL-17RB\/AKT\/\u03b2-catenin pathway to enhance the stemness of gastric cancer","volume":"6","author":"Bie","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.001_bib90","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190297","article-title":"The role of interleukin-17 in tumor development and progression","volume":"217","author":"Zhao","year":"2020","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.cytogfr.2025.12.001_bib91","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.semcancer.2019.12.007","article-title":"The CXCL12-CXCR4\/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies","volume":"65","author":"Daniel","year":"2020","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.cytogfr.2025.12.001_bib92","doi-asserted-by":"crossref","first-page":"12841","DOI":"10.2147\/CMAR.S278902","article-title":"LCN2 Mediated by IL-17 affects the proliferation, migration, invasion and cell cycle of gastric cancer cells by targeting SLPI","volume":"12","author":"Xu","year":"2020","journal-title":"Cancer Manag Res"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.12.001_bib93","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jcmgh.2017.12.012","article-title":"Interleukin-17A Promotes Parietal Cell Atrophy by Inducing Apoptosis","volume":"5","author":"Bockerstett","year":"2018","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.cytogfr.2025.12.001_bib94","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s41419-018-1100-1","article-title":"Degranulation of mast cells induced by gastric cancer-derived adrenomedullin prompts gastric cancer progression","volume":"9","author":"Lv","year":"2018","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.cytogfr.2025.12.001_bib95","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/onc.2016.291","article-title":"The promotion of the transformation of quiescent gastric cancer stem cells by IL-17 and the underlying mechanisms","volume":"36","author":"Jiang","year":"2017","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.cytogfr.2025.12.001_bib96","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cyto.2007.06.002","article-title":"IL-17A versus IL-17F induced intracellular signal transduction pathways and modulation by IL-17RA and IL-17RC RNA interference in AGS gastric adenocarcinoma cells","volume":"38","author":"Zhou","year":"2007","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.cytogfr.2025.12.001_bib97","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1359-6101(03)00002-9","article-title":"Interleukin-17 family and IL-17 receptors","volume":"14","author":"Moseley","year":"2003","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cytogfr.2025.12.001_bib98","doi-asserted-by":"crossref","first-page":"4910595","DOI":"10.1155\/2020\/4910595","article-title":"Expression Levels of IL-17A, IL-17F, IL-17RA, and IL-17RC in Prostate Cancer with Taking into Account the Histological Grade according to Gleason Scale in Comparison to Benign Prostatic Hyperplasia: In Search of New Therapeutic Options","volume":"2020","author":"Janiczek","year":"2020","journal-title":"J. Immunol. Res"},{"issue":"6","key":"10.1016\/j.cytogfr.2025.12.001_bib99","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1593\/neo.07109","article-title":"Differential expression of IL-17RC isoforms in androgen-dependent and androgen-independent prostate cancers","volume":"9","author":"You","year":"2007","journal-title":"Neoplasia"},{"issue":"3","key":"10.1016\/j.cytogfr.2025.12.001_bib100","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15037864","article-title":"Association between IL-17A and IL-17F gene polymorphisms and risk of gastric cancer in a Chinese population","volume":"15","author":"Zhao","year":"2016","journal-title":"Genet Mol. Res"},{"key":"10.1016\/j.cytogfr.2025.12.001_bib101","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2147\/OTT.S151129","article-title":"Association between IL-17A G197A polymorphism and gastric cancer risk: an updated meta-analysis based on 6,624 cases and 7,631 controls","volume":"11","author":"Hu","year":"2018","journal-title":"Onco Targets Ther."},{"issue":"7","key":"10.1016\/j.cytogfr.2025.12.001_bib102","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.humimm.2009.04.030","article-title":"Genetic polymorphism of interleukin-17A and -17F genes in gastric carcinogenesis","volume":"70","author":"Shibata","year":"2009","journal-title":"Hum. Immunol."},{"issue":"7","key":"10.1016\/j.cytogfr.2025.12.001_bib103","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.humimm.2012.04.011","article-title":"Genetic polymorphisms of IL17A and pri-microRNA-938, targeting IL17A 3\u2032-UTR, influence susceptibility to gastric cancer","volume":"73","author":"Arisawa","year":"2012","journal-title":"Hum. Immunol."},{"issue":"34","key":"10.1016\/j.cytogfr.2025.12.001_bib104","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.3748\/wjg.v19.i34.5693","article-title":"Polymorphism in the interleukin-17A promoter contributes to gastric cancer","volume":"19","author":"Rafiei","year":"2013","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.12.001_bib105","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.gene.2013.11.007","article-title":"Effect of interleukin-17A and interleukin-17F gene polymorphisms on the risk of gastric cancer in a Chinese population","volume":"537","author":"Qinghai","year":"2014","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.001_bib106","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.humimm.2014.12.011","article-title":"Association of IL-17A and IL-17F polymorphisms with gastric cancer risk in Asians: a meta-analysis","volume":"76","author":"Liu","year":"2015","journal-title":"Hum. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.001_bib107","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/ijc.25027","article-title":"Association between polymorphisms in interleukin-17A and interleukin-17F genes and risks of gastric cancer","volume":"127","author":"Wu","year":"2010","journal-title":"Int J. Cancer"},{"issue":"18","key":"10.1016\/j.cytogfr.2025.12.001_bib108","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.3748\/wjg.v21.i18.5707","article-title":"Association of IL-17 polymorphisms with gastric cancer risk in Asian populations","volume":"21","author":"Long","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.12.001_bib109","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3892\/ijmm_00000367","article-title":"Association between IL-17A, -17F and MIF polymorphisms predispose to CpG island hyper-methylation in gastric cancer","volume":"25","author":"Tahara","year":"2010","journal-title":"Int J. Mol. Med"},{"issue":"7","key":"10.1016\/j.cytogfr.2025.12.001_bib110","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1007\/s12094-022-02777-z","article-title":"Cytokine-driven positive feedback loop organizes fibroblast transformation and facilitates gastric cancer progression","volume":"24","author":"Cao","year":"2022","journal-title":"Clin. Transl. Oncol."},{"issue":"7423","key":"10.1016\/j.cytogfr.2025.12.001_bib111","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nature11465","article-title":"Adenoma-linked barrier defects and microbial products drive IL-23\/IL-17-mediated tumour growth","volume":"491","author":"Grivennikov","year":"2012","journal-title":"Nature"},{"issue":"7556","key":"10.1016\/j.cytogfr.2025.12.001_bib112","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature14282","article-title":"IL-17-producing \u03b3\u03b4 T cells and neutrophils conspire to promote breast cancer metastasis","volume":"522","author":"Coffelt","year":"2015","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.12.001_bib113","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s13402-020-00510-y","article-title":"IL-17A and IL-17F orchestrate macrophages to promote lung cancer","volume":"43","author":"Ferreira","year":"2020","journal-title":"Cell Oncol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.001_bib114","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13045-020-00897-z","article-title":"Th17 cells inhibit CD8(+) T cell migration by systematically downregulating CXCR3 expression via IL-17A\/STAT3 in advanced-stage colorectal cancer patients","volume":"13","author":"Wang","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.001_bib115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41698-025-00810-2","article-title":"Streptococcus lutetiensis inhibits CD8(+) IL17A(+) TRM cells and leads to gastric cancer progression and poor prognosis","volume":"9","author":"Wang","year":"2025","journal-title":"NPJ Precis Oncol."},{"issue":"8","key":"10.1016\/j.cytogfr.2025.12.001_bib116","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nrc2444","article-title":"The role of myeloid cells in the promotion of tumour angiogenesis","volume":"8","author":"Murdoch","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.001_bib117","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41467-021-27936-8","article-title":"Cancer cell-expressed BTNL2 facilitates tumour immune escape via engagement with IL-17A-producing \u03b3\u03b4 T cells","volume":"13","author":"Du","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.001_bib118","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1158\/2326-6066.CIR-23-0061","article-title":"Tyrosine kinase inhibition activates intratumoral \u03b3\u03b4 T cells in gastrointestinal stromal tumor","volume":"12","author":"Etherington","year":"2024","journal-title":"Cancer Immunol. Res"},{"issue":"10","key":"10.1016\/j.cytogfr.2025.12.001_bib119","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/mc.20661","article-title":"A nonsynonymous polymorphism in IL23R gene is associated with risk of gastric cancer in a Chinese population","volume":"49","author":"Chen","year":"2010","journal-title":"Mol. Carcinog."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.12.001_bib120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.canep.2010.08.006","article-title":"IL23R +2199A\/C polymorphism is associated with decreased risk of certain subtypes of gastric cancer in Chinese: a case-control study","volume":"35","author":"Chen","year":"2011","journal-title":"Cancer Epidemiol."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.12.001_bib121","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"14","key":"10.1016\/j.cytogfr.2025.12.001_bib122","doi-asserted-by":"crossref","first-page":"877","DOI":"10.21037\/atm-20-4843","article-title":"Cancer-associated fibroblasts promote the migration and invasion of gastric cancer cells via activating IL-17a\/JAK2\/STAT3 signaling","volume":"8","author":"Zhang","year":"2020","journal-title":"Ann. Transl. Med"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.001_bib123","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10120-020-01092-2","article-title":"Interleukin-17A derived from mast cells contributes to fibrosis in gastric cancer with peritoneal dissemination","volume":"24","author":"Gunjigake","year":"2021","journal-title":"Gastric Cancer"},{"issue":"6","key":"10.1016\/j.cytogfr.2025.12.001_bib124","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.484","article-title":"Activated neutrophils polarize protumorigenic interleukin-17A-producing T helper subsets through TNF-\u03b1-B7-H2-dependent pathway in human gastric cancer","volume":"11","author":"Shan","year":"2021","journal-title":"Clin. Transl. Med"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.12.001_bib125","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1053\/j.gastro.2012.06.010","article-title":"CD8(+) T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer","volume":"143","author":"Zhuang","year":"2012","journal-title":"Gastroenterology"},{"issue":"18","key":"10.1016\/j.cytogfr.2025.12.001_bib126","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1182\/blood-2008-10-183251","article-title":"IL-17-producing human peripheral regulatory T cells retain suppressive function","volume":"113","author":"Beriou","year":"2009","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cytogfr.2025.12.001_bib127","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1182\/blood-2009-03-208249","article-title":"Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments","volume":"114","author":"Kryczek","year":"2009","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.cytogfr.2025.12.001_bib128","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.7150\/jca.19639","article-title":"Loss of Tff1 Promotes Pro-Inflammatory Phenotype with Increase in the Levels of ROR\u03b3t+ T Lymphocytes and Il-17 in Mouse Gastric Neoplasia","volume":"8","author":"Soutto","year":"2017","journal-title":"J. Cancer"},{"issue":"6","key":"10.1016\/j.cytogfr.2025.12.001_bib129","first-page":"5447","article-title":"Clinical efficacy of apatinib in treating metastatic gastric cancer and its effect on IL-17","volume":"17","author":"Chen","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.cytogfr.2025.12.001_bib130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1186\/1471-2407-10-529","article-title":"Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies","volume":"10","author":"Li","year":"2010","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.cytogfr.2025.12.001_bib131","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00595-015-1165-8","article-title":"Clinical relevance of the number of interleukin-17-producing CD 8+ T cells in patients with gastric cancer","volume":"45","author":"Saito","year":"2015","journal-title":"Surg. Today"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.12.001_bib132","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3892\/ijmm_00000266","article-title":"Effect of polymorphisms of IL-17A, -17F and MIF genes on CpG island hyper-methylation (CIHM) in the human gastric mucosa","volume":"24","author":"Tahara","year":"2009","journal-title":"Int J. Mol. Med"},{"issue":"5","key":"10.1016\/j.cytogfr.2025.12.001_bib133","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1007\/s12032-012-0273-1","article-title":"Expression of interleukin-17 and its clinical significance in gastric cancer patients","volume":"29","author":"Meng","year":"2012","journal-title":"Med Oncol."},{"issue":"9","key":"10.1016\/j.cytogfr.2025.12.001_bib134","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/nm.3333","article-title":"IL-17 mediates resistance to anti-VEGF therapy","volume":"19","author":"Maniati","year":"2013","journal-title":"Nat. Med"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.001_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102429","article-title":"Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies","volume":"19","author":"Ruiz de Morales","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cytogfr.2025.12.001_bib136","first-page":"8494079","article-title":"The Role of Interleukin-17 in Lung Cancer","author":"Wu","year":"2016","journal-title":"Mediat. Inflamm. 2016"},{"key":"10.1016\/j.cytogfr.2025.12.001_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110757","article-title":"IL-17A functions and the therapeutic use of IL-17A and IL-17RA targeted antibodies for cancer treatment","volume":"123","author":"Song","year":"2023","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.cytogfr.2025.12.001_bib138","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17091433","article-title":"Targeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer Type","volume":"17","author":"Fabre","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.12.001_bib139","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cyto.2015.09.011","article-title":"Interleukin-17 acts as double-edged sword in anti-tumor immunity and tumorigenesis","volume":"89","author":"Qian","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2025.12.001_bib140","doi-asserted-by":"crossref","first-page":"5653","DOI":"10.1038\/onc.2010.367","article-title":"Up for Mischief? IL-17\/Th17 in the tumour microenvironment","volume":"29","author":"Maniati","year":"2010","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.cytogfr.2025.12.001_bib141","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1517\/13543784.2013.806483","article-title":"IL-17 targeted therapies for psoriasis","volume":"22","author":"Chiricozzi","year":"2013","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.cytogfr.2025.12.001_bib142","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2147\/CCID.S67534","article-title":"Targeting of interleukin-17 in the treatment of psoriasis","author":"L\u00f8nnberg","year":"2014","journal-title":"Clin. Cosmet. Investig. Dermatol. 7"},{"key":"10.1016\/j.cytogfr.2025.12.001_bib143","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001107","article-title":"Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis","volume":"2","author":"Hueber","year":"2010","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.12.001_bib144","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.semarthrit.2013.04.006","article-title":"Th17 cells and IL-17 a--focus on immunopathogenesis and immunotherapeutics","volume":"43","author":"van den Berg","year":"2013","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2025.12.001_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108402","article-title":"The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases","volume":"102","author":"Berry","year":"2022","journal-title":"Int Immunopharmacol."},{"issue":"26","key":"10.1016\/j.cytogfr.2025.12.001_bib146","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.2174\/1381612829666230904150808","article-title":"Role of Th17 and IL-17 cytokines on inflammatory and auto-immune diseases","volume":"29","author":"Akhter","year":"2023","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.12.001_bib147","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.molmed.2016.01.001","article-title":"IL-17 in Chronic Inflammation: From Discovery to Targeting","volume":"22","author":"Beringer","year":"2016","journal-title":"Trends Mol. Med"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.001_bib148","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-023-01620-3","article-title":"The IL-17 family in diseases: from bench to bedside","volume":"8","author":"Huangfu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cytogfr.2025.12.001_bib149","article-title":"Could the inhibition of IL-17 or IL-18 be a potential therapeutic opportunity for gastric cancer?","author":"Nguyen","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2025.12.001_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188758","article-title":"Targeting interleukin-17 enhances tumor response to immune checkpoint inhibitors in colorectal cancer","author":"Li","year":"2022","journal-title":"Biochim. Et. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.cytogfr.2025.12.001_bib151","doi-asserted-by":"crossref","first-page":"1274431","DOI":"10.3389\/fimmu.2023.1274431","article-title":"Serum cytokines and neutrophil-to-lymphocyte ratio as predictive biomarkers of benefit from PD-1 inhibitors in gastric cancer","volume":"14","author":"Hou","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.001_bib152","article-title":"Interleukin-17 signaling influences CD8+ T cell immunity and tumor progression according to the IL-17 receptor subunit expression pattern in cancer cells","volume":"12","author":"Rodriguez","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.cytogfr.2025.12.001_bib153","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00262-016-1797-6","article-title":"Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic","volume":"65","author":"Majchrzak","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cytogfr.2025.12.001_bib154","article-title":"Targeting the interleukin-17 immune axis for cancer immunotherapy","volume":"217","author":"Vitiello","year":"2019","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.cytogfr.2025.12.001_bib155","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.clinthera.2016.03.026","article-title":"Current challenges in cancer treatment","volume":"38","author":"Zugazagoitia","year":"2016","journal-title":"Clin. Ther."}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610125001510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610125001510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:33:36Z","timestamp":1773880416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610125001510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":155,"alternative-id":["S1359610125001510"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2025.12.001","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The IL-17 axis in gastric carcinogenesis: From inflammation to oncogenic transformation","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2025.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}